Skin treatment system
AssigneeLeonhardt Ventures LLC
InventorsHoward J. Leonhardt, Jorge Genovese
Life of this patent
Estimating the term…
Abstract
A skin regeneration therapy combining precise bioelectric signals, light, and biologics for skin treatment and regeneration. Precise bioelectric signals give clear instructions to the stimulated cell DNA/RNA to produce specific regenerative proteins on demand. Bioelectric signals give clear instructions to cell membranes on what to let in and what to let out and serve as an equivalent or surrogate of environmental stimuli to cause a cell action in response.
Claims16
A method of treating an area of a subject's skin, the method comprising:
- applying the following bioelectric signals to the area of the subject's skin:
- (a) a first bioelectric signal that upregulates expression of stromal cell-derived factor 1 (SDF1) at the treated area;
- (b) a second bioelectric signal that upregulates expression of platelet-derived growth factor (PDGF) at the treated area;
- (c) a third bioelectric signal that upregulates expression of tropoelastin at the treated area;
- (d) a fourth bioelectric signal that upregulates expression of follistatin at the treated area;
- and
- (e) a fifth bioelectric signal that upregulates expression of insulin-like growth factor 1 (IGF-1) at the treated area;
- and
- delivering platelet rich fibrin (PRF) and/or amniotic fluid to the area of the subject's skin.
A method of treating an area of a subject's skin, the method comprising:
- applying the following bioelectric signals to the area of the subject's skin:
- (a) a first bioelectric signal that upregulates expression of stromal cell-derived factor 1 (SDF1) at the treated area;
- (b) a second bioelectric signal that upregulates expression of platelet-derived growth factor (PDGF) at the treated area;
- (c) a third bioelectric signal that upregulates expression of tropoelastin at the treated area;
- (d) a fourth bioelectric signal that upregulates expression of follistatin at the treated area;
- and
- (e) a fifth bioelectric signal that upregulates expression of insulin-like growth factor 1 (IGF-1) at the treated area;
- and
- delivering to the area of skin a skin regeneration composition comprising amniotic fluid, amniotic fluid membranes, platelet rich fibrin (PRF), PRF membranes, and/or nutrient hydrogel.
A method of treating an area of a subject's skin, the method comprising:
- applying the following bioelectric signals to the area of the subject's skin:
- (a) a first bioelectric signal having a frequency of 100 Hz, square wave, or (within 15%) 30 Hz, square wave;
- (b) a second bioelectric signal having a frequency of 10 Hz, square wave, or 100 Hz, square wave;
- (c) a third bioelectric signal having a frequency of (within 15%) 50 Hz, square wave wherein the third bioelectric signal is able to upregulate expression of tropoelastin at the treated area;
- (d) a fourth bioelectric signal having a frequency of (within 15%) 50 Hz, square wave, wherein the fourth bioelectric signal is able to upregulate expression of follistatin at the treated area;
- and
- (e) a fifth bioelectric signal having a frequency of (within 15%) 22 Hz, square wave;
- and
- delivering platelet rich fibrin (PRF) and/or amniotic fluid to the area of the subject's skin.
Dependencies are inferred from the claim text.